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A wide variety of aortic stent-graft designs for
the treatment of aortic aneurysmal disease are under
investigation, and the optimum design or mecha-
nism of aortic fixation is not known. The success of
endoluminal stent-grafts is critically dependent on
secure proximal fixation of the graft; this has often
excluded patients from endoluminal treatment when
the infrarenal aortic cuff has not been of an adequate
length. A bare spring graft component extending 15
mm proximal to the Dacron graft fabric was devel-
oped to obviate these anatomical constraints and
increase the number of eligible patients. However,
clinical experience with transrenal fixation is limited.
Given the potential risk of placing a stent across the
origin of the renal arteries, we prospectively evaluat-
ed our early experience with the transrenal fixation of
aortic stent-grafts to determine patient outcome and
any morbidity, with particular attention being paid to
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Purpose: We evaluated our early experience with the transrenal fixation of aortic stent-
grafts to determine the efficacy of this procedure and its effects on renal artery patency
and hemodynamics.
Methods: Twenty-eight patients (22 men) had endoluminally placed modular bifurcated
stent-grafts with a bare spring structure at the proximal end crossing the origin of both
renal arteries; no patient with infrarenal fixation was included for analysis. The mean age
of the patients was 75 ± 7 years (range, 58-86 years); the mean aneurysm size was 5.8 ±
0.8 cm (range, 4.7-7.2 cm). Eight patients had preoperative or intraoperative angiograph-
ic evidence of renal artery atherosclerotic disease, but only four vessels had luminal nar-
rowing of 50% or greater. No complications were noted during stent-graft placement, and
all patients have returned for follow-up visits, ranging from 1 to 12 months (mean follow-
up, 6 ± 4 months). Follow-up evaluations included clinical assessment, duplex ultrasound
scan of the renal arteries and kidneys, and computed tomographic angiography.
Results: No evidence of lobular or sublobular perfusion defects of the renal parenchyma
was detected postoperatively. Two patients exhibited postoperative changes in renal
artery hemodynamics—one progressing from a 30% diameter reduction to a greater than
60% diameter stenosis at the 12-month follow-up visit and one with a normal renal
artery preoperatively having elevated flow velocities indicative of a greater than 60%
stenosis at the 1-month visit. Of 19 patients with normal preoperative renal function,
only one has had persistently elevated serum creatinine levels. 
Conclusion: We conclude from this experience that the transrenal placement of open stents
is safe and effectively excludes the aneurysm, potentially expanding the availability of this
technique to more patients with a short infrarenal aortic neck. Long-term follow-up is
essential to determine the overall efficacy of this technique and to identify potential effects
on renal artery hemodynamics or kidney function. (J Vasc Surg 2000;32:697-703.)
697
From the Department of Surgery, William Beaumont Hospital,a
and the Department of Surgery, St. John Hospital.b
Competition of interest: PGB and FB have minor share holdings
in the Medtronic Corporation, parent company for World
Medical/AVE.
Presented at the Twenty-eighth Annual Symposium of the
Society for Clinical Vascular Surgery, Rancho Mirage, Calif,
Mar 15-19, 2000.
Reprint requests: Paul G. Bove, MD, William Beaumont
Hospital, 102-VSC, 3601 W. Thirteen Mile Rd, Royal Oak, MI
48073 (e-mail: pbove@beaumont.edu).
Copyright © 2000 by The Society for Vascular Surgery and The
American Association for Vascular Surgery, a Chapter of the
International Society for Cardiovascular Surgery.
0741-5214/2000/$12.00 24/6/110051
10.1067/mva.2000.110051
any effects on renal artery patency and hemodynam-
ics or the development of renal insufficiency.
METHODS
All patients at William Beaumont Hospital, Royal
Oak, Michigan, who have undergone endoluminal
aortic stent-graft repair of infrarenal abdominal aor-
tic aneurysms as part of a Phase II US Food and
Drug Administration elective protocol or emergency
compassionate use protocol were prospectively stud-
ied. The study was approved by our institutional
review board before initiation, and all patients gave
proper informed consent before they were enrolled.
Patients were treated with the TALENT aortic stent-
graft (World Medical Manufacturing Corp, Sunrise,
Fla/Medtronic AVE, Santa Rosa, Calif), which has a
modular design with a Dacron fabric graft and a self-
expandable nitinol wire frame, by a technique of bare
spring transrenal aortic fixation proximally. The bare
spring is a nitinol stent that extends 15 mm proximal
to the graft fabric with a cross-hatched design with
interwire spacing of 7 to 10 mm, depending on over-
all graft diameter, and that crosses the origin of both
renal arteries (Figure).
Baseline demographic data were obtained for all
patients, and preoperative data were recorded on
aneurysm size and morphology, renal function, and
the presence of renal artery obstructive disease docu-
mented by means of angiography and, whenever pos-
sible, duplex ultrasound scan. The anatomical condi-
tion of the renal artery and hemodynamic character-
istics were further documented with the use of intra-
operative angiography. At postoperative follow-up,
we recorded technical and clinical outcomes and any
associated morbidity. Postoperative renal function
was documented by means of the serum creatinine
level (normal, 0.7–1.5 mg/dL) and the blood urea
nitrogen value (normal, 8–22 mg/dL). Surveillance
was done at regular intervals with the use of com-
puted tomographic (CT) angiography plus aortic and
renal artery duplex ultrasound examinations in our
vascular laboratory accredited by the Intersocietal
Commission for the Accreditation of Vascular
Laboratories. Standard duplex ultrasound scan crite-
ria were used to determine the presence of significant
renal artery stenosis—namely, a renal/aortic peak
systolic velocity ratio greater than 3.5, indicating a
stenosis of greater than 60% of the diameter of the
artery. Lesser degrees of luminal narrowing (indicat-
ed by elevation of renal artery peak systolic velocity
above 180 cm/s, with a renal/aortic velocity ratio of
less than 3.5) were noted when present. Because of
the small number of patients in this series with abnor-
mal postoperative renal function and renal artery
hemodynamics, it was thought that no meaningful
statistical analyses could be done.
RESULTS
Between November 1998 and February 2000,
34 patients underwent 35 endoluminal aortic stent
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Drawing of typical stent graft shows the proximal bare spring nitinol stent that extends above the ori-
gin of the renal arteries.
graft repair procedures, including six patients
enrolled in the emergency/compassionate use pro-
tocol. Of these, 3 patients had thoracic aortic
aneurysm stent-grafts placed, 1 patient had a aorto-
uni-iliac graft placed proximal to a cadaveric renal
transplant, and 1 patient had conversion to an open
aorto-bifemoral repair after an unsuccessful attempt
at femoral access. Patients with pure infrarenal fixa-
tion of the stent-graft were excluded from further
analysis, leaving 28 patients who had placement of
aortic stent grafts with transrenal proximal fixation
across both renal arteries who form the basis of this
report (Table I). 
There were 22 men (79%) and six women, with
an average age of 75.0 ± 7.5 years (range, 58–86
years). The mean aneurysm size was 5.8 ± 0.8 cm,
ranging from 4.7 to 7.2 cm in diameter. The length
of the aortic neck from the renal artery origin to the
aneurysm was 22.0 ± 11.6 mm, with eight patients
(29%) having this neck length of less than 15 mm;
aortic diameter just below the origin of the renal
arteries averaged 26.4 ± 3.6 mm, with seven patients
(25%) having infrarenal aortic diameters of 30 mm
or greater. Intraoperatively, two patients (7%)
required the placement of temporary arterial con-
duits to gain access to the aorta.
Postoperative follow-up ranged from 1 to 12
months, with a mean follow-up of 6 ± 4 months
(Table II). Three patients had type II endoleaks iden-
tified before their discharge from the hospital; two of
these have resolved, one spontaneously by 6 months
and one after successful placement of a second iliac
limb to treat what actually was a graft failure at 6
months. One small type II endoleak persisted at the 1-
month follow-up evaluation with CT angiography. No
patient left the operating room with a type I endoleak;
however, there was a type I endoleak in one patient at
the 6-month follow-up examination and this necessi-
tated the placement of a proximal aortic cuff of larger
dimension. A persistent seal of the endoleak was noted
3 months after the secondary procedure. At the time
of this writing, there have been no deaths in this series
of transrenal fixation patients.
Preoperatively, eight patients (29%) had elevated
blood urea nitrogen levels; six of these eight were
mild, between 22 and 25 mg/dL. Four of these
patients also had elevated creatinine levels, none
exceeding 2.0 mg/dL. An additional patient with a
normal blood urea nitrogen level had a preoperative
creatinine level of 1.6 mg/dL. Of these nine patients
with an abnormality of routinely assessed preopera-
tive renal function, only one was noted by angiogra-
phy to have renal artery atherosclerotic disease, a
40% ostial diameter reduction in the left renal artery.
Eight of these nine patients had persistently elevated
creatinine or blood urea nitrogen levels, or both,
postoperatively at the time of their most recent fol-
low-up visit, with six of the eight having persistently
elevated levels of both parameters. The five patients
with elevated preoperative serum creatinine levels
have all had persistent elevation postoperatively, and
three of those five had a greater than 20% increase
from their preoperative levels, persisting an average
of 4 months. Of the 19 patients with normal preop-
erative renal function test findings, 9 had elevated
postoperative blood urea nitrogen levels and 4 of
these also had concomitant elevated serum creati-
nine levels. These postoperative elevations in blood
urea nitrogen have persisted in only three patients,
and all three of these patients were noted by preop-
erative angiography to have renal artery atheroscle-
rotic disease; only one of these three patients also
had a persistently elevated serum creatinine value.
Intraoperative contrast utilization averaged 216 ±
70 cc (range, 60 to 350 cc) for the entire group of
28 patients. No differences were seen between sub-
groups based on preoperative or postoperative renal
function in terms of contrast load (Table II); for
example, patients with abnormal preoperative and
postoperative function test results averaged 217 cc
of contrast, versus those patients who went from
normal to persistently abnormal postoperative func-
tion test results, who averaged 207 cc of contrast.
Angiographic evidence of renal artery stenosis
consistent with atherosclerotic disease was seen pre-
operatively in eight patients, involving 11 of 16 renal
arteries. Four vessels had measured stenoses of 50%
diameter reduction or greater, including one having a
70% diameter stenosis and one having a 60% diameter
stenosis. All four of these stenoses were confirmed by
means of duplex ultrasound scan examination, with
no progression of the stenosis or worsening of the
hemodynamic measurements noted during the post-
operative follow-up period. One patient with a 30%
left renal artery narrowing as seen on both preopera-
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 4 Bove et al 699
Table I. Patient demographics (N = 28)
Male/female 22/6
Age (range) 75 ± 7 y (58-86 y)
Aneurysm size (range) 5.8 ± 0.8 cm (4.7 -7.2 cm)
Preoperative
Renal artery stenosis > 50% 4 pts
Elevated BUN/creatinine 9 pts (BUN 26 ± 4; 
creatinine 1.8 ± 0.1)
BUN, Blood urea nitrogen.
tive and intraoperative angiography (contralateral to a
60% right renal artery stenosis) had postoperative
duplex ultrasound scan measurements at the 12
months’ follow-up examination consistent with a
greater than 60% left renal artery diameter reduction.
This patient had normal preoperative renal function
but persistently elevated levels of blood urea nitrogen
and serum creatinine postoperatively. A second
patient with no angiographic evidence of preoperative
renal artery stenosis had postoperative duplex ultra-
sound scan findings consistent with a greater than
60% right renal artery stenosis (renal/aortic peak sys-
tolic velocity ratio of 3.6 and a renal artery peak sys-
tolic velocity of 170 cm/s); this patient had abnormal
renal function test results preoperatively and had per-
sistently elevated levels of blood urea nitrogen and
serum creatinine postoperatively. Given the relatively
short follow-up of this patient (6 weeks), it is not yet
certain if this was due to the development of a stenot-
ic lesion or if it was a false-positive result of the duplex
scan examination. One patient who had known bilat-
eral renal artery stenoses had a successful aortic stent-
graft placed and in the postoperative period under-
went a left renal artery angioplasty with placement of
a stent at an outside facility by another practitioner
without the knowledge of the investigators. At fol-
low-up examination, both interventions have been
durable to 6 months and the contralateral kidney has
not had an angioplasty. There has been no change in
blood pressure management or renal function.
Twenty-five patients had no evidence of any change in
renal artery anatomy or hemodynamics detected by
postoperative duplex ultrasound scan or CT angiog-
raphy. Postoperative gray-scale duplex ultrasound
scan images of the kidneys have remained normal in
all patients, and no localized perfusion defects have
been identified with power Doppler scan imaging of
the renal parenchyma or with postoperative CT
angiography. No patient has had deterioration in
blood pressure control or has required intensification
of antihypertensive therapy.
DISCUSSION
A significant design consideration for endolumi-
nal stent-grafts used to treat abdominal aortic dis-
ease is the secure fixation of the proximal end of the
stent-graft to avoid graft migration and to prevent
the occurrence of an endoleak around the graft into
the aneurysm sac. This requirement limited the
application of early stent graft designs to patients
with a long aortic cuff between the origin of the
renal arteries and the aneurysmal dilation to accom-
modate the fixation device. Typically, such prosthe-
ses required at least a 15-mm proximal neck; thus,
most patients with aortic aneurysms who were eval-
uated for possible stent-graft placement during the
early development of these techniques were exclud-
ed from endoluminal treatment. In this study, the
stent-graft design allows for the placement of an
open nitinol wire frame across the renal artery ori-
gins bilaterally to aid in fixation at the proximal end
of the graft, but there is very little follow-up infor-
mation available on the clinical and hemodynamic
consequences of such placement.
Malina et al1 reported on a median 6-month 
follow-up of 18 patients with transrenal fixation of the
proximal segment of Gianturco Z stent grafts. Spiral
CT and angiography showed continued patency of all
25 renal arteries affected, with no evidence of renal
artery compromise; CT did show a small infarct in
one kidney. Serum creatinine levels remained stable
for the group, as did the group’s mean blood pres-
sure, though one patient did require intensification of
antihypertensive therapy after stent graft placement.
Similarly, MacIerewicz et al2 compared 19 patients
with transrenal fixation with modified Gianturco Z
stents to 11 patients with infrarenal stent graft fixa-
tion. Short-term follow-up with use of radionuclide
renography, serum creatinine levels, and glomerular
filtration rates showed no significant differences
between the two groups for any parameter measured.
Duda et al3 reported on a mean 10-month follow-
up of seven patients with juxtarenal implantation of
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Table II. Postoperative results
Deaths 0 pts
Follow-up (range) 6 ± 4 mo (1-12 mo)
Progressive renal artery stenosis 2 vessels Intraoperative contrast
Elevated BUN persisting postop 7/8 pts (28 ± 6) 217 ± 56 cc
Elevated Cr persisting postop 5/5 pts (2.2 ± 0.4) 191 ± 57 cc
Normal preop renal function
Transient postop BUN/Cr elevation 6 pts 238 ± 43 cc
Persistent elevated postop BUN 3 pts (33 ± 10) 207 ± 102 cc
Persistent elevated postop Cr 1 pt (1.6) 150 cc
BUN, Blood urea nitrogen; Cr, creatinine.
nitinol-polyester coknit stent-grafts with infrarenal
neck lengths ranging from 3 to 14 mm. Postoperative
CT, captopril renography, and laboratory analyses
showed no impairment of renal function or perfusion.
Marin et al4 used self-manufactured devices in 37
patients with transrenal placement of the proximal
porous portion of a Palmaz balloon–expandable
stent/expandable polytetrafluoroethylene (ePTFE)
graft configuration. Two patients had a device malpo-
sition with inadvertent coverage of a renal artery by
the ePTFE endograft, resulting in nondialysis depen-
dent renal insufficiency. Compared with a group of 16
patients with infrarenal stent graft placement at a mean
follow-up of 10 months, the remaining 35 patients
had no clinical changes in their hypertensive status or
therapy requirements and no significant changes in
serum creatinine levels. CT and angiography showed
no significant renal artery compromise for appropri-
ately positioned stents or progression of preexisting
renal artery atherosclerotic disease. Segmental renal
infarction was seen in two patients. Of incidental note
in this series was a significantly higher proximal
endoleak rate for stent-grafts placed in the infrarenal,
versus transrenal, position.
The results of our series of 28 patients with
transrenal fixation of the proximal segment of the
stent graft are comparable with these studies. Blood
urea nitrogen and creatinine data are presented for
completeness, although, admittedly, alterations in
these levels may be caused by a number of factors.
Of nine patients with preoperative renal dysfunction,
eight have shown persistent abnormalities in their
serum creatinine and blood urea nitrogen levels, and
three of these eight patients have had a persistent
elevation of serum creatinine of greater than 20%.
Walker et al5 reported that in 149 patients with nor-
mal renal function preoperatively there was a post-
procedure rate of renal dysfunction of 9% (serum
creatinine level elevated > 20% above baseline) after
endovascular repair of abdominal aortic aneurysms
without regard to position of the proximal fixation.
At a mean follow-up of 6 months, for the 19 patients
in our series with normal preoperative renal function
test results, only one has had a persistently elevated
serum creatinine level (5%), elevated from a preop-
erative value of 1.3 mg/dL to a postoperative level
of 1.6 mg/dL. Although small numbers of patients
in the various subgroups of patients with some
degree of renal dysfunction noted preoperatively or
postoperatively (or both) do not allow meaningful
statistical analysis, no large differences in intraopera-
tive contrast load was seen for any of these groups
compared with the mean contrast load for the entire
group (216 cc). CT angiography and duplex ultra-
sound scan evaluation have shown no evidence of
any renal infarcts or parenchymal perfusion defects.
Duplex ultrasound scan evaluation of the renal
arteries postoperatively has shown worsening hemo-
dynamic changes in only two vessels. Neither of
these patients had a preoperative duplex ultrasound
scan examination, so the postoperative duplex ultra-
sound scan data can be compared only with preop-
erative and intraoperative angiographic assessments.
In one renal artery noted preoperatively to have an
approximate 30% diameter reduction (contralateral
to a 60% diameter stenosis), postoperative findings
at 12 months were consistent with a greater than
60% diameter stenosis bilaterally; this is the single
patient with persistently elevated serum creatinine
level. These findings likely represent progressive
renal artery atherosclerotic disease—which is not
entirely surprising, given the natural history of renal
artery atherosclerosis, which shows a 3-year rate of
progression in this range of stenoses of 50% to 60%.
The second patient had normal renal artery anatomy
preoperatively and at 6-weeks follow-up had duplex
ultrasound scan findings that were borderline for
significant stenosis; that is, a renal/aortic peak sys-
tolic velocity ratio of 3.6 and an absolute renal artery
peak systolic velocity of 170 cm/s. With this brief
follow-up of only 6 weeks it is yet to be determined
if this represents a true stenotic lesion or a false-
positive result of the duplex scan examination. This
patient had preoperative renal dysfunction that per-
sisted throughout the short follow-up as well.
Our study does not address the question of opti-
mal treatment for coexisting renal artery stenoses.
Only 11 renal arteries were noted preoperatively to
have evidence of atherosclerotic disease, and only four
of these had lesions causing 50% diameter reductions
or greater. The data did not show significant correla-
tion between the presence of renal artery disease and
outcomes, with only one patient with preoperative
renal dysfunction noted to have renal artery athero-
sclerotic disease, and the one patient with disease pro-
gression noted above to have abnormal postoperative
serum creatinine levels. These small numbers and
short length of follow-up do not allow any conclu-
sions to be drawn on the advisability of treating such
lesions preoperatively or whether diligent surveillance
is a better approach. Preoperative renal interventions
offer the possibility of better blood pressure control
and possible preservation of renal function, but even
minor complications could impact the ability to place
an aortic stent-graft. Compromise of an already exist-
ing aortic stent-graft repair is a real concern in post-
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DISCUSSION
operative renal artery interventions. The relatively
short follow-up of this series also does not provide
sufficient data to draw any conclusions on the possi-
ble role, if any, of transrenal stent-graft fixation on the
progression of renal artery atherosclerotic disease, and
the small numbers of patients in the subgroups with
preoperative and postoperative renal dysfunction, or
either, do not allow meaningful statistical analyses.
We can conclude from this experience that the
transrenal placement of open stents can be done safe-
ly, with good early results and with minor morbidity,
potentially expanding the availability of this technique
to patients with a short infrarenal aortic neck. It can-
not be determined whether the changes in renal func-
tion and in renal artery hemodynamics that were
observed are related solely to the transrenal design of
the aortic stent graft or are multifactorial. Long-term
follow-up is needed to determine whether this tech-
nique will ultimately have any deleterious effect on
renal artery hemodynamics or kidney function.
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Dr Alan B. Lumsden (Atlanta, Ga). I enjoyed your
paper. Successful endovascular repair of an aortic
aneurysm clearly requires the hemostatic seal between the
graft and the underlying aortic wall. Transrenal fixation
then rationally could be proposed essentially for two rea-
sons. First of all, it provides optimal graft fixation even in
patients in whom there is an adequate infrarenal neck,
albeit that we really haven’t defined what an optimal neck
length actually is. Secondly, you’d apply it in a patient in
whom the neck length is deemed by current standards to
be inadequate. Currently, we are looking at less than 1 to
1.5 cm. The slight problem with this series is it really rep-
resents a mixture of these two indications. The Talent
device used by the authors, of course, as they mentioned
has both an open spring and a closed stent formation. It’s
the open spring model being designed specifically for the
patient with a short neck. If we really look at the proximal
neck in the patients who were treated in this series, of 28
patients, they had a mean neck length of 22 ± 11.6 mm.
As an average, 22 mm would generally be regarded as
pretty generous in most contemporary series. Only eight
patients in the series had a neck length of less than 15 mm,
but the authors really don’t provide us any data on just
how short these necks actually were, how many had indi-
cations that were actually less than 10 mm. The neck
diameter was also actually fairly large. The average was
26.4 ± 3.6 mm. That’s generally fairly large and would
actually have excluded most of these patients from the cur-
rently approved FDA devices. And some seven patients
had diameters greater than 30 mm. So clearly, at least
some of these patients had frankly challenging necks, and
the other things, which of course, add to the degree of dif-
ficulty are the degrees of neck angulation. You certainly
showed one example but really didn’t comment on what
percentage of these patients had neck angulation greater
than 60%.
In the result section, the authors note two type II
endoleaks but emphasize that no patient left the operating
room with a type I endoleak. This implies that it is easy to
tell at the time of a completion angiogram and frankly it’s
sometimes a little more difficult than is often presented to
actually distinguish a type II versus a type I endoleak intra-
operatively, and I’d like to hear what angiographic maneu-
vers the authors go through when they identify an
endoleak to try and exclude the fact that this is actually a
graft leak.
The focus of this paper is on renal function, and we
look specifically at some of the renal function in these
patients. You noted that one patient had a normal renal
artery on the preoperative evaluation and yet on the 1-
month follow-up was noted on duplex scanning to have a
stenosis > 60%. This would imply to me that this is either
an imaging error or a device-related problem and com-
promising the origin of that single renal artery. Five
patients had abnormal preoperative creatinine levels.
Three of those five patients were found to have a greater
than 20% elevation at the 1-month follow-up. Clearly, that
indicates that the patient as we know with elevated creati-
nine is obviously at risk, but there was also one patient
with a normal preoperative creatinine who also had a
greater than 20% sustained elevation in his creatinine. Of
interest is also the patient who had the bilateral untreated
renal artery stenosis who then went on to have a left renal
artery stent placement. It would be interesting to know (if
you have any information on that) whether that was a
more difficult procedure as a result of it.
In summary, there are really very little published data
regarding suprarenal fixation, and consequently this is
really a welcome addition. Nevertheless, there is so clearly
some limitations basically on this study, and I have several
questions for the authors. Number one is what do you
really mean by suprarenal fixation? Several of these
patients had more than adequate neck length of infrarenal
fixation, and just what did you do with these patients? Did
you really try to align the endograft flush with the inferi-
or margin of the lowest renal artery and was suprarenal fix-
ation essentially equal in all of these different patients? 
Number two is contrast load. I think it’s absolutely
essential in a paper like this when we’re looking at renal
function that there is really no mention of how much con-
trast these patients were given at the time of implantation.
Clearly, we think the patients with the more difficult necks
may be the ones who need a higher contrast load in order
to adequately deploy that flush on the renal artery. So do
you have any data on the type of contrast you use and
whether there is any correlation in the amount of dye and
subsequent renal function? 
Number three is, just again, what angiographic steps
do you use to track down an endoleak intraoperatively, and
I’d definitely like you to comment on the two interesting
patients, the one with the left renal artery stenosis who was
subsequently treated and the second one. What do you
really think happened to that patient who in the course of
1 month went from a normal renal artery to 60% stenosis? 
I enjoyed the paper. I think it’s a major contribution
and appreciate the opportunity to review it.
Dr Juan Paraodi (Buenos Aires, Argentina). I think there
are two main reasons to do suprarenal fixation: first, to
obtain a complete sealing and better attachment of the stent-
graft and second, to decrease the incidence of endoleak. We
need some basic studies, and we need data so everybody
knows that the strongest part of the aorta can be used. 
There is no question that this is the way to go. There is
some conflicting data coming from Europe. Malina report-
ed a 25% incidence of small infarcts, but at the same time he
recorded in the infrarenal fixations a little less than 25%.
That would mean that we are embolizing not only after, but
also during the procedure. We know there is diastolic reflux
that can embolize the internal iliac arteries, so the incidence
of this is real. I believe that the open frame devices should
take care of this, and we will have some open spaces to pre-
vent any kind of problems in the future placement. We all
know that renal stenosis > 75% tends to occlude the artery,
so those patients probably need stenting of the renal arter-
ies. It is good to have an open space to prevent emboliza-
tion and also to access the renal arteries.
The last comment is related to the contrast media, and
we all know there is decreased renal function in patients
with poor perfusion. What we do now is we use gadolini-
um for our studies and haven’t had any change in renal
function postprocedure.
Dr Paul Bove. I’d like to thank Drs Lumsden and
Parodi for their comments. In the comments, several ques-
tions came up as well in addition to the specific questions
proposed. First, why apply this technique to patients who
have what would normally be considered a long neck, and
unfortunately, I think when you’re doing this you get into
the concept that more is better. And that longer fixation
distance is a better thing. Certainly some of those patients
did have specific degrees of angulation where we wanted a
longer fixation and then even though the neck length may
have been 22 mm or greater some of that is still diseased,
although it’s not aneurysmal, and so those can be reasons,
but I don’t have the angulation data or the amount of dis-
ease in the neck quantitated in any way.
I was interested to see that our average neck diameter
was slightly greater than 26 mm as well because in utiliz-
ing any of the FDA-approved grafts, that would have
excluded those patients. I can’t believe that that is due to
any bias in measurement just because there would be no
reason to abnormally increase the neck diameter. But I just
found it as an interesting thing. 
You are absolutely right. It can be difficult to identify
a type I endoleak in the operating room. There are simple
angiographic maneuvers that we employ, for example,
when you do your contrast injection, identify the timing
of the filling of the aneurysm sac. If it’s immediate filling
as you see the bolus pass through the proximal portion,
then you can assume that there is a type I leak from that
proximal anastomosis. If you see the lumbars filling and
then you see the aneurysm fill, then oftentimes that would
be a type II leak. Doing selective injections into each iliac
limb can also help identify a type I versus a type II leak.
But you’re right, there are few absolute ways to determine
whether a type I leak has been ruled out.
With regard to possible etiologies for the progression
of renal artery stenosis, certainly one possibility would be
placement of the graft immediately infrarenal, and
although we don’t know how these grafts completely heal,
certainly it could be a portion of the healing process with a
buildup of fibrin and thrombus right at that healing edge.
And I suppose a shoulder or a collar lesion may be identi-
fied. None of these patients other than the patient who was
actually treated by another physician had an invasive test to
further identify that. I do have a few MRIs that are pend-
ing. Specifically with the patient who was treated, I don’t
know the specifics. It was sort of a funny story in that when
he came back for his postoperative renal duplex, the tech-
nologist came to me, showed me the films. and it was nor-
mal. I said, “You absolutely must have missed something.”
I went back into the room with him, watched it again and
then the patient said, “Oh yeah, my cardiologist did this
last week and so it was a total shock to me.” But he has
done okay. There has been no change in his status.
You’re right, I agree including contrast data would be
important. I can say as a generalization that our contrast
load was less than 200 cc. I don’t believe in any cases that
did go over 250 cc. Generally, we used Omnipaque-350
for our power injections and 240 for hand injections.
Thank you.
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